Want to see AU:PAR full AI Analyst Report?
Paradigm Biopharmaceuticals (PAR) Income Statement
46 Followers
Paradigm Biopharmaceuticals Income Statement
Last quarter (Q4 2026), Paradigm Biopharmaceuticals's total revenue was AU$55.00K, a decrease of 16.41% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals's net income was AU$-33.09M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 80.15K | AU$ 52.12K | AU$ 65.80K | AU$ 46.76K | AU$ 79.22K | |
| AU$ -82.37K | AU$ -19.89K | AU$ 56.81K | AU$ -18.83K | AU$ -64.53K | |
| AU$ 61.03M | AU$ 22.87M | AU$ 65.10M | AU$ 60.07M | AU$ 47.93M | |
| Depreciation and Amortization | AU$ 150.39K | AU$ 51.42K | AU$ 146.74K | AU$ 153.66K | AU$ 193.25K |
| AU$ -60.96M | AU$ -25.25M | AU$ -64.54M | AU$ -59.06M | AU$ -46.82M | |
| AU$ -61.11M | AU$ -22.89M | AU$ -65.19M | AU$ -59.22M | AU$ -47.01M | |
| AU$ -2.84M | AU$ -2.42M | AU$ 6.54M | AU$ 263.61K | AU$ -1.48K | |
| AU$ -63.95M | AU$ -25.30M | AU$ -58.65M | AU$ -58.95M | AU$ -47.01M | |
| AU$ -56.33M | AU$ -18.77M | AU$ -58.65M | AU$ -51.91M | AU$ -39.25M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.15 | AU$ -0.06 | AU$ -0.20 | AU$ -0.18 | AU$ -0.16 |
| Diluted EPS | AU$ -0.15 | AU$ -0.06 | AU$ -0.20 | AU$ -0.18 | AU$ -0.16 |
| Weighted Average Shares Outstanding | 370.03M | 314.50M | 293.28M | 289.68M | 240.96M |
| Weighted Average Shares Outstanding (Diluted) | 370.03M | 314.50M | 293.28M | 289.68M | 241.82M |
Currency in AUD
